Free CME from PeerView


Pathology CME

Kurt A. Schalper, MD, PhD/Vamsidhar Velcheti, MD
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment
February 15, 2024
Jessica Donington, MD/Jonathan D. Spicer, MD, PhD, FRCSC
Credits: 1.0 CME / MOC / CC / AAPA
PVI, PeerView Institute for Medical Education
A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC
January 28, 2024
Joshua Sabari, MD
Credits: 0.75 CME / MOC / CC
PeerView Institute for Medical Education
Mastering the Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in Advanced NSCLC
January 25, 2024
Manmeet S. Ahluwalia, MD, MBA, FASCO
Credits: 0.25 CME
PVI, PeerView Institute for Medical Education
Brainstorming New Approaches to Improve Glioblastoma Care: Revolutionary Advances With Modern Gene Fusion–Targeted Therapy
December 28, 2023
Erika Hamilton, MD
Credits: 1.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer: Risk Assessment, Prognostic Testing, and Selection and Sequencing of Therapies
December 07, 2023
Sara A. Hurvitz, MD, FACP
Credits: 1.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Modern Practice Principles: A Practical “How-To” Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2-Positive Breast Cancer
December 06, 2023
Credits: 1.0 CME / MOC / CC / AAPA
PVI, PeerView Institute for Medical Education
Polishing Management Protocols in HER2-Expressing GI Cancers With Targeted Agents: A Focus on Refining Team-Based Strategies to Individualize BTC and GEA Care
June 08, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Progress on the Path to Improving Outcomes in the Treatment of SCLC: Making the Most of Current Standard-of-Care Therapies and Exploring New Promising Research
June 04, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
March 23, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
March 21, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies: Practical Strategies for Biomarker Testing and Pathologic Response Assessment
March 13, 2023
Credits: 1.5 CME / MOC / CC
PVI, PeerView Institute for Medical Education
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer: Exploring the Biology and Updating Best Practices for Testing and Treatment
March 12, 2023
Credits: 1.5 CME / CC
PVI, PeerView Institute for Medical Education
The Precision Team in AML: Exploring Pathologist-Informed Clinical Decisions in Challenging AML Settings
March 12, 2023
Credits: 1.0 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Seizing the Precision Care Moment in MDS: Collaborative Strategies for Accurate Diagnoses and Risk-Adapted Treatment
March 12, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment
March 01, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?
February 26, 2023
PVI, PeerView Institute for Medical Education
Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations: Navigating Testing and Treatment Throughout the Disease Continuum
February 22, 2023
PVI, PeerView Institute for Medical Education
Fine-Tuning Biomarker Testing to Identify and Target RET Fusions as Uncommon But Actionable Genomic Alterations in NSCLC
January 29, 2023
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
January 20, 2023
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
September 25, 2022
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
September 01, 2022
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
June 04, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
April 09, 2022